Eurofarma Acquires Segmenta

BMI View: We believe that a growing number of drugmakers in Latin America will step up efforts to increase their market presence domestically and regionally, driven by strong demand, double-digit growth rates and the potential for high returns. This view is supported by consolidation among local drugmakers and expansion into smaller subsectors of the generic

To read the full article, please choose one of the following options: